A clinical trial to compare the effects of two drugs, bupivacaine and ropivacaine in combination with fentanyl in labour pain relief
Phase 1
Recruiting
- Registration Number
- CTRI/2010/091/000150
- Lead Sponsor
- Sant Parmanand Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
1. Primigravida
2. ASA I & II physical status
3. The age group 18-30 yrs
4. Established labour and with cervical dilatation of 3-5cm
Exclusion Criteria
1. ASA physical status of 3 or more.
2. Age less than 18yrs or more than 30 yrs.
3. Administration of parentral analgesics before epidural injection
4. Patients with local infection at the site of injection or bleeding disorders
5.Multiple gestation.
6.Inability to understand how to use PCEA pump.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the analgesic effects of ropivacaine and bupivacaine in combination with fentanyl during labor?
How does the efficacy of ropivacaine 0.2% + fentanyl 2µg/ml compare to bupivacaine 0.1% + fentanyl 2µg/ml in patient-controlled epidural analgesia for labor pain?
Are there specific biomarkers that predict better patient outcomes with ropivacaine versus bupivacaine in labor analgesia?
What are the known adverse events associated with patient-controlled epidural analgesia using ropivacaine or bupivacaine in combination with fentanyl, and how are they managed?
What are the current trends in local anesthetic combinations with opioids for labor pain management beyond CTRI/2010/091/000150?